中国临床医学
中國臨床醫學
중국림상의학
Chinese Journal of Clinical Medicine
2015年
5期
631-632
,共2页
马强%陈卓%贾国金%金伟%陆雪强%谢雪锋
馬彊%陳卓%賈國金%金偉%陸雪彊%謝雪鋒
마강%진탁%가국금%금위%륙설강%사설봉
慢性前列腺炎%喹诺酮%α受体阻滞剂%舍尼通
慢性前列腺炎%喹諾酮%α受體阻滯劑%捨尼通
만성전렬선염%규낙동%α수체조체제%사니통
Chronic prostatitis%Quinolone%Alpha blocker%Prostat
目的:探讨联合药物治疗慢性前列腺炎的疗效。方法:按照美国国立卫生研究所(NIH)制定的慢性前列腺炎症状指数(CPSI)标准结合两杯判定试验(PPM T )及前列腺按摩液(EPS)常规检查对253例慢性前列腺炎患者进行NIH分类以及疗效判定。253例均应用喹诺酮类抗生素治疗2~4周并联合α受体阻滞剂及舍尼通治疗4~6周。结果:按NIH制定的CPSI分类,253例患者中Ⅱ型23例(9.1%),ⅢA型109例(43.1%),ⅢB型121例(47.8%)。治疗6周后根据CPSI评分判定疗效:治愈18.6%,显效45.5%,有效14.6%,无效21.3%,总有效率77.7%。治疗后平均白细胞数(WBC )为(5.4±1.6)个/高倍镜视野(HP),与治疗前[(24.6±3.8)个/HP]比较,差异有统计学意义(P<0.05)。23例Ⅱ型前列腺炎患者治疗后,PPMT 结果显示,19例转为阴性,转阴率为82.6%。结论:CPSI是一种较好的疗效评价方法。联合应用喹诺酮类抗生素、α受体阻滞剂及舍尼通治疗前列腺炎的效果满意。
目的:探討聯閤藥物治療慢性前列腺炎的療效。方法:按照美國國立衛生研究所(NIH)製定的慢性前列腺炎癥狀指數(CPSI)標準結閤兩杯判定試驗(PPM T )及前列腺按摩液(EPS)常規檢查對253例慢性前列腺炎患者進行NIH分類以及療效判定。253例均應用喹諾酮類抗生素治療2~4週併聯閤α受體阻滯劑及捨尼通治療4~6週。結果:按NIH製定的CPSI分類,253例患者中Ⅱ型23例(9.1%),ⅢA型109例(43.1%),ⅢB型121例(47.8%)。治療6週後根據CPSI評分判定療效:治愈18.6%,顯效45.5%,有效14.6%,無效21.3%,總有效率77.7%。治療後平均白細胞數(WBC )為(5.4±1.6)箇/高倍鏡視野(HP),與治療前[(24.6±3.8)箇/HP]比較,差異有統計學意義(P<0.05)。23例Ⅱ型前列腺炎患者治療後,PPMT 結果顯示,19例轉為陰性,轉陰率為82.6%。結論:CPSI是一種較好的療效評價方法。聯閤應用喹諾酮類抗生素、α受體阻滯劑及捨尼通治療前列腺炎的效果滿意。
목적:탐토연합약물치료만성전렬선염적료효。방법:안조미국국립위생연구소(NIH)제정적만성전렬선염증상지수(CPSI)표준결합량배판정시험(PPM T )급전렬선안마액(EPS)상규검사대253례만성전렬선염환자진행NIH분류이급료효판정。253례균응용규낙동류항생소치료2~4주병연합α수체조체제급사니통치료4~6주。결과:안NIH제정적CPSI분류,253례환자중Ⅱ형23례(9.1%),ⅢA형109례(43.1%),ⅢB형121례(47.8%)。치료6주후근거CPSI평분판정료효:치유18.6%,현효45.5%,유효14.6%,무효21.3%,총유효솔77.7%。치료후평균백세포수(WBC )위(5.4±1.6)개/고배경시야(HP),여치료전[(24.6±3.8)개/HP]비교,차이유통계학의의(P<0.05)。23례Ⅱ형전렬선염환자치료후,PPMT 결과현시,19례전위음성,전음솔위82.6%。결론:CPSI시일충교호적료효평개방법。연합응용규낙동류항생소、α수체조체제급사니통치료전렬선염적효과만의。
Objective:To explore the efficacy of combination drug therapy for chronic prostatitis .Methods:According to National Institute Health Chronic Prostatitis Syndrome Index (NIH‐CPSI) combined with the pre‐ and post‐ massage test (PPMT) and expressed prostatic secretion (EPS) routine examination ,the NIH classification and efficacy evaluation was conducted for 253 patients with chronic prostatitis .All the 253 cases were administered quinolone antibiotics for 2 to 4 weeks , and meanwhile were administered alpha blocker and prostat for 4 to 6 weeks .Results:According to NIH‐CPSI ,there were 23 (9 .1% ) cases of type Ⅱ ,109(43 .1% ) cases of type Ⅲ A and 121(47 .8% ) cases of type Ⅲ B among the 253 patients .After 6 weeks of treatment ,the patients were evaluated by CPSI and the results showed that the curative rate ,the remarkable effective rate ,the improving rate ,the ineffective rate ,the total effective rate was 18 .6% ,45 .5% ,14 .6% ,21 .3% ,and 77 .7% , respectively .The average WBC count in EPS was (5 .4 ± 1 .6)/HP after the treatment ,while it was (24 .6 ± 3 .8)/HP before the treatment .And the difference was statistically significant (P< 0 .05) .After the treatment ,23 patients with chronic bacterial prostatitis underwent bacterial culture by using PPMT ,19 of which turned negative with a turning negative rate of 82 .6% .Conclusions:NIH‐CPSI is a reliable method for efficacy evaluation .The combination of drugs ,including quinolone , alpha blockade and prostat ,shows satisfactory effect for the treatment of chronic prostatitis .